Morgan Stanley
ELV icon

Morgan Stanley’s Elevance Health ELV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.18B Buy
3,039,465
+66,356
+2% +$25.8M 0.08% 228
2025
Q1
$1.29B Buy
2,973,109
+104,911
+4% +$45.6M 0.09% 195
2024
Q4
$1.06B Sell
2,868,198
-584,569
-17% -$216M 0.07% 234
2024
Q3
$1.8B Buy
3,452,767
+225,768
+7% +$117M 0.13% 140
2024
Q2
$1.75B Buy
3,226,999
+273,155
+9% +$148M 0.14% 141
2024
Q1
$1.53B Sell
2,953,844
-2,853,526
-49% -$1.48B 0.12% 159
2023
Q4
$2.74B Buy
5,807,370
+3,022,656
+109% +$1.43B 0.12% 158
2023
Q3
$1.21B Buy
2,784,714
+46,322
+2% +$20.2M 0.12% 150
2023
Q2
$1.22B Sell
2,738,392
-24,049
-0.9% -$10.7M 0.12% 161
2023
Q1
$1.27B Sell
2,762,441
-180,764
-6% -$83.1M 0.14% 147
2022
Q4
$1.51B Buy
2,943,205
+465,102
+19% +$239M 0.17% 123
2022
Q3
$1.13B Buy
2,478,103
+18,094
+0.7% +$8.22M 0.15% 132
2022
Q2
$1.19B Buy
2,460,009
+980,223
+66% +$473M 0.15% 135
2022
Q1
$727M Sell
1,479,786
-221,355
-13% -$109M 0.1% 202
2021
Q4
$789M Buy
1,701,141
+51,202
+3% +$23.7M 0.1% 209
2021
Q3
$615M Buy
1,649,939
+81,314
+5% +$30.3M 0.08% 227
2021
Q2
$599M Buy
1,568,625
+113,659
+8% +$43.4M 0.08% 226
2021
Q1
$522M Sell
1,454,966
-103,998
-7% -$37.3M 0.08% 242
2020
Q4
$501M Buy
1,558,964
+274,659
+21% +$88.2M 0.08% 229
2020
Q3
$345M Buy
1,284,305
+32,411
+3% +$8.71M 0.07% 258
2020
Q2
$329M Sell
1,251,894
-91,031
-7% -$23.9M 0.07% 243
2020
Q1
$305M Buy
1,342,925
+70,925
+6% +$16.1M 0.08% 212
2019
Q4
$384M Buy
1,272,000
+5,294
+0.4% +$1.6M 0.09% 214
2019
Q3
$304M Buy
1,266,706
+84,298
+7% +$20.2M 0.08% 248
2019
Q2
$334M Buy
1,182,408
+378,897
+47% +$107M 0.09% 231
2019
Q1
$231M Sell
803,511
-148,679
-16% -$42.7M 0.07% 298
2018
Q4
$250M Buy
952,190
+275,378
+41% +$72.3M 0.07% 270
2018
Q3
$185M Buy
676,812
+268,900
+66% +$73.7M 0.05% 375
2018
Q2
$97.1M Sell
407,912
-38,333
-9% -$9.12M 0.03% 589
2018
Q1
$98M Sell
446,245
-139,587
-24% -$30.7M 0.03% 604
2017
Q4
$132M Sell
585,832
-131,611
-18% -$29.6M 0.04% 485
2017
Q3
$136M Buy
717,443
+111,949
+18% +$21.3M 0.04% 433
2017
Q2
$114M Sell
605,494
-388,008
-39% -$73M 0.03% 513
2017
Q1
$164M Buy
993,502
+142,818
+17% +$23.6M 0.05% 376
2016
Q4
$122M Buy
850,684
+347,684
+69% +$50M 0.04% 458
2016
Q3
$63M Buy
503,000
+20,322
+4% +$2.55M 0.02% 730
2016
Q2
$63.4M Buy
482,678
+76,098
+19% +$9.99M 0.02% 681
2016
Q1
$56.5M Sell
406,580
-78,069
-16% -$10.9M 0.02% 696
2015
Q4
$67.6M Buy
484,649
+29,711
+7% +$4.14M 0.02% 652
2015
Q3
$63.7M Sell
454,938
-719,221
-61% -$101M 0.02% 665
2015
Q2
$193M Buy
1,174,159
+467,723
+66% +$76.8M 0.07% 314
2015
Q1
$109M Sell
706,436
-716,020
-50% -$111M 0.04% 478
2014
Q4
$179M Buy
1,422,456
+342,199
+32% +$43M 0.07% 320
2014
Q3
$129M Buy
1,080,257
+167,248
+18% +$20M 0.05% 415
2014
Q2
$98.3M Buy
913,009
+28,208
+3% +$3.04M 0.04% 521
2014
Q1
$88.1M Sell
884,801
-99,411
-10% -$9.9M 0.04% 517
2013
Q4
$90.9M Buy
984,212
+41,079
+4% +$3.8M 0.04% 491
2013
Q3
$78.9M Buy
943,133
+92,067
+11% +$7.7M 0.04% 492
2013
Q2
$69.7M Buy
+851,066
New +$69.7M 0.04% 512